Citation:Gomez-Guerra LS, Martinez-Fierro ML, Alcantara-Aragon V, Ortiz-Lopez R, Martinez-Villarreal RT, Morales-Rodriguez IB, et al 2009

From Clinical Guidelines Wiki

Citation


Gomez-Guerra LS, Martinez-Fierro ML, Alcantara-Aragon V, Ortiz-Lopez R, Martinez-Villarreal RT, Morales-Rodriguez IB, et al. Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases. BMC Cancer 2009 Mar 24;9:91 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/19317909.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, what is the incremental value of performing a DRE in addition to PSA testing in detecting any prostate cancer?Dr. med. univ. Dana Stefanoviccompleted
For men without a prostate cancer diagnosis or symptoms that might indicate prostate cancer, what is the incremental value of performing a DRE in addition to PSA testing in detecting any prostate cancer?Cindy Pengcompleted

Compare quality appraisals for each clinical question

Cited by

  1. Role of digital rectal examination